Hot Stocks

The stock market changes from minute to minute, and what’s hot today may not be hot tomorrow. Our expert analysts spot hot stocks that are heating up before the crowd swoops in to bid prices higher, and our journalists sift through the noise to shine a light on trending investments -- in spaces ranging from quantum computing to marijuana stocks -- to determine whether they’re actually worth your time.

4 California Stocks to Keep On Hold Until Post-Coronavirus

These four strong California stocks deserve your attention and further due diligence to be included in long-term portfolios.

EV News: AYRO Stock Soars 63% on Factory Expansion

Ayro (AYRO) stock is in the news Monday after announcing the completion of an expansion to its electric vehicle (EV) factory.

Lucky Brand Bankruptcy: Store Closings and 6 Other Things to Know

A Lucky Brand bankruptcy is underway and it will have the company closing down some of its stores and selling off its business.

Uber Stock Gets a 5% Lift From $2.65B Postmates Deal

Uber (UBER) is seeing its stock rise on Monday after announcing a $2.65 billion deal to acquire food-delivery service Postmates.

Dominion Energy Stock Falls 10% on $10B Natural Gas Assets Sale to Buffett’s Berkshire

Dominion Energy (D) stock is taking a beating Monday after announcing the sale of its natural gas assets to Berkshire Hathaway (BRK.A,BRK.B).

Did Warren Buffett Contribute to Occidental Pete’s Demise?

For those unfamiliar with Buffett’s relationship with Occidental, his company lent OXY $10 billion last August to help it acquire Anadarko, beating out Chevron (NYSE:CVX) in the process. In hindsight, Chevron’s CEO has got to be ecstatic it lost the fight.

Beware of Nio’s Lofty Valuation

The high price of Nio stock is largely based on the rallies of Nikola and Tesla, so investors may want to wait for a better entry point before buying Nio's shares

Nio News: Why NIO Stock Is Rocketing 19% Higher Today

Nio (NIO) news for Monday concerning a sales update that came out last week has NIO stock on the rise as gains on Friday.

It’s Definitely Time to Take Profits on Nio

Nio stock has had a fantastic run, but there's no reason to be greedy. This is a great time to close your position and enjoy your winnings.

Delisting Is the Final Blow for Luckin Stock

The delisting of Luckin stock isn't just a technical matter, but yet another sign of the company's indifference to U.S. shareholders.

Yes, Callon Petroleum Is Better Than Its Rivals

Not all oil and gas investments are wildly speculative affairs, as CPE stock demonstrates. Unfortunately, the broader narrative is just ugly for all players within this industry.

Life After Chesapeake: 7 Energy Stocks to Buy

Oil stocks have gone into the bargain bin thanks to the pandemic and Saudi-Russia price war. But what's the long-term future for these stocks?

Remain Calm and Gradually Add to Your Position in Carnival

The first half of 2020 was so bad for the cruise-line industry that CCL stock, in the long run, has nowhere to go but up.

IBM Partnership and Rising Covid-19 Cases Are Lifting iBio Stock

Fears of a second coronavirus wave have Covid-19 focused biotech stocks surging again. So where does IBIO stock fit into the mix?

CallingDr a Play for the Red-Hot Telemedicine Space

Launched to help with the hurricanes, the firm has a full platform for care. But due diligence is wise if you plan to invest in Calling Dr.

Bed Bath & Beyond Earnings Preview: Pessimism Could Lead to a Positive Surprise

With the fiscal data about to be released, BBBY stock traders must weigh the company's challenges against the possibility of an earnings beat.

For DraftKings Stock, A Lot Rides on the Return of Sports

DraftKings stock has done well with people staying at home, but for it to see real growth, we need to see a return of sports to bet on.

Right Now, iBio Stock Is Even More Risky Than You Might Have Thought

Buying a stock because it could be part of the solution to coronavirus is a risky way to play an already volatile market. IBIO stock's weak financials make it all the more dependent on coronavirus drugs to deliver.

Inovio Pharmaceuticals Comes Up Short in Phase 1

The competition for a Covid-19 vaccine is intense. Inovio needs to provide investors with more information to give INO stock a chance at long-term upside.